Psychological & Psychiatric Care Evidence

A meta-analysis of 94 interview-based studies found depression prevalence of approximately 29% across oncological, hematological, and palliative care settings. Depression is the most common psychiatric diagnosis in patients with advanced illness and is systematically under-identified and undertreated.

A 2023 systematic review of psychological distress interventions in palliative care populations found substantial heterogeneity in both prevalence estimates and intervention outcomes. Effect sizes varied widely across settings, making it difficult to draw uniform conclusions about the effectiveness of any single intervention approach across all patients.

The CALM (Managing Cancer and Living Meaningfully) RCT demonstrated that a brief, manualized individual psychotherapy significantly reduced depressive symptoms and improved preparedness for death in patients with advanced cancer, compared to usual care.

In a single-blind randomized trial (Mehnert et al. 2020, N=206), depressive symptoms improved over six months in both arms, but CALM was not significantly better than non-manualized supportive counselling on the primary outcome (BDI-II P=.62; PHQ-9 P=.998), and secondary outcomes were also non-significant — the active ingredients of psychological benefit in palliative settings are not yet established.

The dignity therapy RCT (Chochinov et al., 2011) found no statistically significant reduction in distress or depression on primary quantitative endpoints versus usual care. However, patients receiving dignity therapy reported significant improvements in sense of dignity, meaning, and will to live — important qualitative benefits that standard distress scales may not fully capture.

The Meaning-Centered Group Psychotherapy (MCGP) RCT (Breitbart et al., 2015) demonstrated significant reductions in spiritual distress and hopelessness, and improvements in spiritual well-being, in patients with advanced cancer compared to supportive group psychotherapy.

Demoralization syndrome — characterized by hopelessness, helplessness, and existential despair — is a clinically distinct condition relevant to palliative populations. It requires different assessment and intervention strategies than standard antidepressant-focused depression protocols.

A meta-analysis of HADS diagnostic accuracy in oncology and palliative settings found moderate sensitivity and specificity for identifying depression and anxiety. HADS performs best as a screening instrument rather than a diagnostic tool; abnormal scores should prompt clinical interview rather than serving as a standalone diagnosis.

The CMS CY2025 Physician Fee Schedule Final Rule (CMS-1807-F) confirms Collaborative Care Model (CoCM) and Behavioral Health Integration (BHI) billing codes under Medicare — providing a reimbursement pathway for integrated behavioral health services in primary care and palliative settings.

The HOPE (Hospice Outcomes and Patient Evaluation) assessment tool — the CMS-mandated quality reporting instrument beginning October 2025 — contains a spiritual and existential concerns item (F3000) but does NOT include the PHQ-2, PHQ-9, GAD-7, HADS, or any standardized depression or anxiety severity instrument. HOPE captures spiritual process items only; psychological severity screening remains outside the standardized HOPE measurement framework.

A systematic review and meta-analysis (Rayner et al., 2011) found that antidepressants are more effective than placebo for treating depression in palliative care populations. However, trial quality was generally low, sample sizes were small, and heterogeneity was substantial — evidence supports clinical use but with recognition of a thin evidence base compared to non-palliative depression treatment literature.

Meaning-Centered Psychotherapy for Cancer caregivers (MCP-C; NCT06307535, Mount Sinai) is an active randomized trial with planned enrollment of 200.

In the Valued Living RCT (Arch et al. 2026, N=240 adults with advanced solid tumor and significant depression/anxiety), a 5-session videoconference ACT intervention delivered by social workers significantly increased advance-care-planning steps completed (primary outcome: +1.27 steps; 95% CI 0.36–2.18; d=0.36; P=.006) and improved spiritual well-being (secondary: d=0.42; P<.001). Fear of death and anxiety did not improve significantly (null secondary endpoints).

In a culturally adapted ENABLE pilot RCT for heart failure in Singapore (Neo et al. 2026), a nurse-led palliative care intervention improved patient KCCQ score at 6 months (primary outcome: +12.4 points; 95% CI 0.9–24.0; d=0.43). Spiritual well-being (FACIT-Sp) improved in both arms. Caregiver quality of life did not differ significantly at 3 or 6 months (null caregiver endpoint).

A 2026 systematic review of music therapy in advanced cancer (Iturri et al., six controlled trials, 438 participants) found no significant change in global quality of life. Spiritual well-being (P=0.04) and ego-integrity (P<.01) improved, every trial reported reduced anxiety, and sleep quality improved (P=0.006 to P=0.012).

A 2026 systematic review of meaning-in-life centered interventions in palliative care (Rodrigues-Fouto & Reis-Pina) identified 8 studies, 7 of which had high risk of bias; the authors concluded evidence is insufficient to recommend meaning-in-life interventions for routine clinical practice.

A quasi-experimental study at Mayo Clinic (Creech et al. 2026; N=200) is evaluating whether chaplaincy care reduces 30-day hospital readmissions; the protocol has been published (PMID 42381114) but no efficacy results are available.